Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn's Disease.
Chulkina M, Rohmer C, McAninch S, Panganiban RP, Villéger R, Portolese A, Ciocirlan J, Yang W, Cohen C, Koltun W, Valentine JF, Cong Y, Yochum G, Beswick EJ, Pinchuk IV.
Chulkina M, et al. Among authors: panganiban rp.
J Crohns Colitis. 2024 Aug 6;18(7):1147-1161. doi: 10.1093/ecco-jcc/jjae009.
J Crohns Colitis. 2024.
PMID: 38224550